Referenties

  1. Alinovi A, Bassissi P and Pini M (1986) Systemic administration of antibiotics in the management of venous ulcers Journal of the American Academy of Dermatology 15 : (2) : 186-191 (part 1)
  2. Bello YM, Falabella AF, De Carbalho H, Nayyar G and Kirsner RS (2001) Commentary: infection and wound healing WOUNDS 13 : (4) : 127-131
  3. Bolton LL (2004) Moist wound healing from past to present In: Rovee DT and Maibach HI (eds) The epidermis in wound healing. Boca Raton - London. CRC Press. pp 89-101
  4. Campbell MJ (2003) What is evidence? In: Mani R (ed) Chronic Wound Management. Boca Raton - London. The Parthenon Publishing Group. pp 11-22
  5. Coombs TJ. Hesrch Soc Serv J 1981; 91(4768): 1268-9
  6. Data on file, JJM TJR. JJML. 00001.
  7. Data on file, Systagenix Wound Management (US), Inc; Data on file, JJM TJR. JJML. 0001.
  8. Dow G, Browne A and Sibbald RG (1999) Infection in chronic wounds: controversies in diagnosis and treatment. Ostomy Wound Management. 45 : (8) : 23-40
  9. Dow G, Browne A and Sibbald RG (1999) Infection in chronic wounds: controversies in diagnosis and treatment. Ostomy/Wound Management. 45 : (8) : 23-40
  10. Ehrlich HP and Gottrup F (1998) Experimental models in wound healing. In : Leaper DJ and harding KG (eds) Wounds: biology and management pp 41-51
  11. Gardner SE, Frantz RA, Troia C, Eastman S, MacDonald M, Buresh K and Healy D (2001) A tool to assess clinical signs and symptoms of localized infection in chronic wounds: development and reliability. Ostomy Wound Management 47 : (1) : 40-47
  12. Hayward P, Hokanson J, HeggersJ, Fiddes J, Klingbeil C, Goeger M and Robson MC (1992) Fibroblast growth factor reverses the bacterial retardation of wound contraction. Am J Surg. 163 : 288-293
  13. Hinman CD and Maibach H (1963) Effect of air exposure and occlusion on experimental human skin wounds. Nature. 200 : 377-379
  14. Janda JM, Abbott SL and Brenden RA (1997) Overview of the etiology of wound infections with particular emphasis on community-acquired illnesses. Eur J Clin Microbiol Inf Dis 16 : (3) : 189-201
  15. Systagenix Wound Management Medical, UK 97007/9.4.
  16. Majno G and Joris I (2004) Cells, tissues and disease, 2nd edition. Oxford University Press. New York - Oxford
  17. Majno G and Joris I (2004) Cells, tissues and disease: wound healing p 483 New York, Oxford University Press
  18. Meaume S, Vallet D. Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care. 2005;14(9):411-419.
  19. Millward, P. British Journal of Nursing, 1995, Vol. 4, No. 15.
  20. Ovington LG (2001) Wound dressings: their evolution and use. In: Falanga V (ed.) Cutaneous wound healing p.221-232. London: Martin Dunitz Ltd.
  21. Percival SL, Bowler PG and Russell D (2005) Bacterial resistance to silver in wound care. J Hosp Infection. 60 : 1-7
  22. Pollock MR (1948) Unsaturated fatty acids in cotton wool plugs. Nature. 161 : 853
  23. Robson MC et al. Wound healing srcerations caused by infection. Clinics in Plastic Surgery 1990; 17: 485-492.
  24. Robson MC, Edstrom LE, Krizek TJ and Groskin MG (1974) The efficacy of systemic antibiotics in the treatment of granulating wounds Current Problems in Surgery 38 : (2) : 61-140
  25. Robson MC, Edstrom LE, Krizek TJ and Groskin MG (1974) The efficacy of systemic antibiotics in the treatment of granulating wounds. J Surg Res. 16 : (4) : 299-306
  26. Robson MC, Mannari RJ, Smith PD and Payne WG (1999) Maintainance of wound bacterial balance. Am J Surg. 178 : 399-402
  27. Robson MC, Steed DL and Franz MG (2001) Wound healing: biological features and approaches to maximize healing trajectories Current Problems in Surgery 38 : (2) : 61-140
  28. Rotstein OD, Pruett TL and Simmons RL (1985) Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis. 7 : (2) : 151-170
  29. Russell AD et al. Progress in Medical Chemistry 1994; 31.
  30. Sapico FL, Ginunas VJ, Thornhill-Joynes M, Canawati HN, Capen DA, Klein NE, Khawam S and Montgomerie JZ (1986) Quantitative microbiology of pressure sores in different stages of healing. Diagn Microbiol and Infect Dis. 5 : 31-38
  31. Schultz GS and Mast BA (1998) Molecular analysis of the environment of healing and chronic wounds: cytokines, proteases and growthfactors. WOUNDS. 10 : (Suppl F) : 1F-9F
  32. Steed DL, Donohoe D, Wenster MW, Lindsley L and the Diabetic Ulcer Study Group (1996) Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg. 183 : 61-64
  33. Stotts NA (1995) NPUAP Proceedings : Determination of bacterial burden in wounds. Adv Wound Care. 8 : (4) : 28-47
  34. Tarnuzzer RW and Schultz GS (1999) Biochemical analysis of acute and chronic wound environments. Wound Rep Reg. 4 : (3) : 321-325
  35. Tomic-Canic M, Ågren MS and Alvarez OM (2004) Epidermal repair and the chronic wound. In : Rovee DT and maibach HI (eds) The epidermis in wound healing pp 26; Boca Raton - CRC Press
  36. Wood RAB (1976) Disintegration of cellulose dressings in open granulating wounds. Britsh Medical Journal. 3 : 1444-1445
  37. Wysocki AB (2002) Evaluating and managing open skin wounds: colonization versus infection. AACN Clinical Issues. 13 : (3) : 382-397
  38. Young, T et al. Proceedings of the European Conference on Advances in Wound Management, 1997, Macmillan Magazines Ltd, London.
  39. Vin F, Teot L, Meaume S. The healing properties of Promogran in venous leg ulcers. J Wound Care. 2002 Oct;11(9):335-341.
  40. Delchambre, J et al. The effect of activated silver impregnated charcoal dressing on delayed healing wounds: - analysis of open multi-center observational studies. Data on file, Post - Marketing Surveillance Studies ACTISORB™ 1996 - 2000; 12,444 Patients. SAWC (2003) Poster Presentation.
  41. Tebbe B et al. Therapy of leg ulcers and decubitus ulcers with a Xerodressing: Modern wound dressing with antibacterial activity. H+G Special Ed. 1996;71 (9): 697-702. 15. Boothman S et al. In vitro evaluation of broad spectrum antimicrobial activity of ACTISORB™ Silver 220 by adsorption efficacy log10 reduction and zone of inhibition tests. July 2002; Report No. 507, Systagenix Wound Management Data on file.
  42. De-Voy K. Silver ACTISORB™ Survival Test. 08.08.1985. Systagenix Wound Management Data on file.
  43. Frost MR. Charcoal Cloth - addition of bactericidal properties. Silver ACTISORB™ 19.10.84. Systagenix Wound Management Data on file.
  44. Boothman S et al. In vitro evaluation of broad spectrum antimicrobial activity of ACTISORB™ Silver 220 by adsorption efficacy log10 reduction and zone of inhibition tests. July 2002; Report No. 507, Systagenix Wound Management Data on file.
  45. Kramer A et al. Studies on the Microbicidal Efficacy of Wound Dressings [Untersuchungen zur Mikrobizidie von Wundauflagen]. Hyg Med. 25 (5): 184-6.
  46. Russel AD et al. Antimicrobial activity and action of silver. Progress in Medicinal Chemistry. 31, 351-370, Elsevier Service 1994.
  47. Milward PA. Nursing Times 1991; 87(13):70-72.
  48. Leak, K. PEG site infections: a novel use for ACTISORB™ Silver 220.Br J Community Nurs. 2002; 7 (6)
  49. Kramer A et al Antibacterial activity and endotoxin-binding capacity of ACTISORB™ Silver 220. J Hospital Infect. 2003; 53: 511-4.
  50. Robson MC et al. Wound healing alterations caused by infection. Clinics in Plastic Surgery 1990; 17: 485-492
  51. Price PE et al. J Wound Care; 9(2):93-95
  52. McLure A.R. et al. Journal of Hospital Infection. 1992 Aug; 21(4):291-9
  53. Goldenheim P.D. Postgrad. Med. Jnl., 1993; 69 (suppl. 3): S97-S105
  54. Langley. INADINE™ wound dressings speed healing, reduce patient discomfort and cuts costs by almost 40%. Burns 1989 Vol.15.
  55. Adams I. Wound healing altered with the use of povidone iodine. 1985
  56. Han K.H. et al. Management of partial skin thickness burn wounds with INADINE™ dressings. Burns 1989 Vol.15 (6) 399-402.
  57. Schulz H-J et al. Clinical evaluation of TIELLE™ Plus dressing in the management of exuding chronic wounds. Br J Community Nurs. 2003:8(11 Suppl);18-22.
  58. Dykes PJ. The effect of adhesive dressing edges on cutaneous irritancy and skin barrier function. J Wound Care 2007;16(3):97-100.
  59. Schulz H-J et al. Evaluating a superabsorbent hydropolymer dressing for exuding venous leg ulcers. J Wound Care 2001:10(1);511-518
  60. Taylor A et al. A noncomparative multicentre clinical evaluation of a new hydropolymer adhesive dressing. J Wound Care. 1998: 8(10);489-492.
  61. Diehm, C. & Lawall, H. Evaluation of Tielle™ hydropolymer dressings in the management of chronic exuding wounds in primary care. Intl Wound J, 2005:2(1); 26-35.
  62. Naylor W. Using a new foam dressing in the care of fungating wounds. Brit J Nursing 2001:10(6); S24-S30.
  63. Teot L et al. The management of wounds using SILVERCEL™ Hydro-Alginate. Wounds UK Supplement. 2005.1(2)
  64. Addison D et al. An Antimicrobial Dressing for moderate to heavily exuding infected and critically colonised wounds. Systagenix Wound Management Gargrave U.K. Poster presented at EWMA Pisa May 2003.
  65. Rennison T et al. Evaluations of a silver Hydro-Alginate dressing to Determine suitability for use on chronic wounds. Systagenix Wound Management Gargrave U.K. Poster presented at EWMA Prague May 2006.
  66. Addison D et al. An evaluation of the Antimicrobial Properties and Silver Release Profile of an Antimicrobial Silver Alginate Wound Dressing. Systagenix Wound Management Gargrave. Poster presented at SAWC San Diego April 2005.
  67. Addison D et al. Evaluation of the Antimicrobial Properties, silver release profile and Absorbency characteristic of a Antimicrobial Silver Hydro-Alginate Wound Dressing. Systagenix Wound Management Gargrave. Poster presented at Wounds U.K. Conference Harrogate Nov 2005.
  68. Clark R, PhD; Stephens S-A, BSc (Hons); Del Bono, M; Abioye, O; Bayliff S, BSc (Hons). Simulated in-use tests to evaluate a non-adherent antimicrobial silver alginate wound dressing. SAWC, Texas, Dallas 2009.
  69. Hart J. Evaluation of a novel non adherent antimicrobial silver alginate/CMC wound dressing in the Porcine partial-thickness excisional wound model. Cica Biomedical (Wound Healing Research) Ltd.
  70. Data on file. Systagenix Wound Management.
  71. Meaume S, Vallet D. Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care. 2005;14(9):411-419.
  72. Pourhassan S, Clinical evidence for the effort of sequential use of wound treatments using a “Clean, Close and Cover” approach. EWMA 2009.
  73. Hollinworth H and Collier M. Nurses' view about pain and trauma at dressing changes: results of a national survey. J Wound Care 2000 : 9 : 369-73
  74. EWMA Position Document: pain at wound dressing changes. European Wound Management Association, 2002
  75. Terill PJ and Varughese G. A comparison of three primary non-adherent dressings applied to hand surgery wounds. J Wound Care 2000 : 9 : 359-63
  76. De-Voy K. Silver ACTISORB™ Survival Test. 08.08.1985. Systagenix Wound Management Data on file.
  77. Frost MR. Charcoal Cloth - addition of bactericidal properties. Silver ACTISORB™ 19.10.84. Systagenix Wound Management Data on file.
  78. Welling, Dr. C. Silver White Paper – the use of silver in wound therapy. Data on file. July 2007.
  79. Young T et al (1997) 6th European Conf Adv. Wound mgt Macmillan Ltd-London
  80. Data on file, Systagenix Wound Management (US), Inc., 2006.
  81. Wysocki AB, Staniano-Coico L, Grinnell F. Wound Fluid from Chronic Leg Ulcers Contains Elevated Levels of Metalloproteinases MMP-2 and MMP-9. J Invest Dermatol. 1993;101:64-8.
  82. Cullen B. The role of oxidized regenerated cellulose/collagen in chronic wound repair. Part 2. Ostomy Wound Manage. 2002 Jun;48(6 Suppl):8-13.
  83. Data on file, Systagenix Wound Management
  84. Cullen B, Watt PW, Lundqvist C, et al. Characterisation of collagen/ORC, a novel biomaterial for wound healing: An investigation of potential mechanisms of action. Int J Biochem Cell Biol. 2002; 34 (12): 1544–56.
  85. Richard JL, Parer-Richard C, Daures JP, et al. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomised, double blind, placebo controlled study. Diabetes Care. 1995; 18: 64-9
  86. Hessenauer U, Renner R. Wegweiser, Lokaltherapie. Serie diabetisches Fyndrom, Teil 4. MMW Munch Med Wochenschr. 142 (39): 739-40.
  87. Vin F, Teot L, Meaume S. The healing properties of Promogran in venous leg ulcers. J Wound Care. 2002 Oct;11(9):335-41.
  88. Data on file, Systagenix Wound Management (US), Inc., 2006.
  89. IMS Data, 1998-2005.
  90. Wieman T, et al. Efficacy and Safety of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients with Chronic Neuropathic Diabetic Ulcers. Diabetes Care. 1998;21(5):822-7.
  91. Steed DL, et al. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg. 1995;21:71-81.
  92. Margolis D, et al. Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers. Wound Repair and Regeneration. 2005;13:531-536.

  93. Thomas et al. A comparison of two dressings in the management of chronic wounds. J Wound Care 1997:6 (8);383-386
  94. Vin F, Teot, L and Meaume S (2002) J Wound Care. 11: (9): 335-41
  95. J. Hart et al. / The International Journal of Biochemistry & Cell Biology 34 (2002) 1557–1570
  96. B. Cullen et al. / The International Journal of Biochemistry & Cell Biology 34 (2002) 1544–1556
  97. B. Cullen / The Role of Oxidized Regenerated Cullulose Collagen in Chronic Wound Repair, Ostomoy Wound Management 48 (2002) 8-13.
  98. VRE: Rennison et al (2003) Silver 220 ETRS Poster (Lab Data)
  99. Bactigras / Smith & Nephew Wound Management, Hull, UK
  100. Boothman S et al. In vitro evaluation of broad spectrum antimicrobial activity of ACTISORB™ Silver 220 by adsorption efficacy log10 reduction and zone of inhibition tests. July 2002
  101. Report No. 507, Systagenix Wound Management Data on file.
  102. Thomas S (1990) Semipermeable Film Dressings. In: Wound Management and Dressings. London. The Pharmaceutical Press. Pages 25-34
  103. Menaker G and Wilcher GD (2003) Dressings. In: Bolognia et al. Dermatology Vol II. Edinburgh - London. Mosby, An Imprint of Elsevier Science. Pages 2255-2268
  104. Jones V, Grey JE and Harding KG (2006) Wound Dressings. In: Grey and Harding (eds) ABC of Wound Healing. Malden - Oxford. Blackwell Publishing Ltd. BMJ Books. Pages 31-34
  105. Pollard T (2009) Films. In: Wound Care Handbook 2009-2010 The comprehensive guide to product selection. London. MA Healthcare Ltd. Pages 96-103
  106. DYNA-FLEX™ Multi-Layer Compression System Performance Compared to a Four- Layer System, George P. Hansen, PhD, 1997.
  107. Hart, J. & Bell, A. (2009) Evaluation of a novel non-adherent antimicrobial silver alginate/CMC wound dressing in the porcine partial -thickness excisional wound model. Poster at Wounds UK conference, Harrogate.
  108. Data on file. Systagenix Wound Management
  109. Meaume S, Vallet D. Evaluation of a silver - releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care. 2005;14(9):411-419.